MBX
Mbx Biosciences
$60.94
−$1.97 (−3.13%)Sep 10, 2026
Key metrics
The numbers that frame MBX today
- Market cap
- $2.93B
- P/E (TTM)
- -28.1
- EV / FCF
- -33.9
- ROIC
- -34.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $9.63
- 52wk High
- $72.64
Growth
Revenue and earnings trend for MBX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MBX
Is Mbx Biosciences a good buy?
Hold. Mbx Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Mbx Biosciences is selling at a high price.
What is the market capitalization of MBX?
Mbx Biosciences's market capitalization is $2.93B.
What is the P/E ratio for MBX stock?
Mbx Biosciences's current P/E ratio is -28.1.
What is the 52-week high for MBX stock?
The 52-week high for Mbx Biosciences is $72.64. The current close of $60.94 is 16.1% below that high.
What is the 52-week low for MBX stock?
The 52-week low for Mbx Biosciences is $9.63. The current close of $60.94 is 532.8% above that low.
Does MBX stock pay dividends?
Mbx Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MBX?
Mbx Biosciences's Debt / Equity ratio is 0.01.